Providing effective hemophilia treatment options is a goal NCHS shares with payers and hemophilia drug manufacturers. We believe that working with payers to select appropriate treatments and drug manufacturers to support patient therapy will help our patients achieve the best outcomes possible.

Payers: Reducing Hemophilia and Bleeding Disorder Medical Costs While Improving Clinical Outcomes

As a specialty pharmacy, NCHS focuses on controlling the costs of hemophilia treatment options through expert clinical oversight. We incorporate a comprehensive and coordinated model of care for patients with hemophilia and other bleeding disorders.

NCHS cares for the whole patient by providing integrated therapy management to support physician-prescribed hemophilia treatment guidelines and non-clinical services that include education, counseling, and community support.

As a leader in the industry with strong manufacturer relationships, we have the buying power to maintain consistent and adequate inventories of product, reducing treatment costs for patients and payers and increasing patient adherence.

NCHS payer services are offered to:

  • Traditional health insurers
  • Managed care organizations
  • Preferred provider organizations
  • Third-party administrators
  • At-risk health providers
  • Self-insured plans
  • Provider network managers
  • And others

NCHS also provides a variety of services to assess, educate, and support hemophilia and bleeding disorder patients while achieving the best economic and clinical outcomes, including:

  • Therapy management
  • 24/7 availability of clinical pharmacists
  • Authorizations and claims management
  • Coordination of claims process and reporting
  • Outcomes reporting for health plans
  • Patient adherence monitoring to capture optimal therapy value
  • Cost control through accurate dosing and dispensing
  • Experienced management of hemophilia and other bleeding disorders

Contact us to learn more about how we control costs and provide exceptional service to our patients.

Hemophilia Drug Manufacturers: The Expertise You Need to Reach Patients

NCHS is dedicated to treating hemophilia, other bleeding disorders, and rare chronic conditions accurately, responsively, quickly, and safely. We share a common goal with pharmaceutical manufacturers: optimal patient clinical outcomes. As a provider of specialty pharmacy and healthcare services, we partner with drug manufacturers to distribute new products to the patients that can benefit from them.

Understanding Your Challenges and Goals

We know how important it is that your hemophilia products are used correctly and that patients receive appropriate support. We assist patients with obtaining effective care and properly administering hemophilia medications through home infusion. The relationships we forge with patients through education and counseling services ensure that protocols are strictly followed and outcomes carefully reported. This leads to greater adherence, improved disease management, and more favorable results for our patients.

Contact us to learn more about how partnering with NCHS can lead to better hemophilia and bleeding disorder treatment solutions.